Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,865 | 162 | 99.8% |
| Education | $4.64 | 1 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $1,042 | 51 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $564.41 | 37 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $370.56 | 25 | $0 (2021) |
| Merck Sharp & Dohme Corporation | $142.18 | 9 | $0 (2019) |
| Allergan, Inc. | $140.61 | 9 | $0 (2020) |
| AstraZeneca Pharmaceuticals LP | $126.59 | 8 | $0 (2022) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $113.89 | 6 | $0 (2024) |
| ABBVIE INC. | $94.63 | 4 | $0 (2023) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $91.70 | 4 | $0 (2024) |
| PFIZER INC. | $83.34 | 6 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $320.45 | 8 | Janssen Pharmaceuticals, Inc ($176.47) |
| 2023 | $172.03 | 7 | Janssen Pharmaceuticals, Inc ($82.71) |
| 2022 | $171.62 | 9 | Boehringer Ingelheim Pharmaceuticals, Inc. ($64.40) |
| 2021 | $304.18 | 15 | Janssen Pharmaceuticals, Inc ($154.29) |
| 2020 | $246.75 | 12 | Janssen Pharmaceuticals, Inc ($144.27) |
| 2019 | $452.43 | 33 | E.R. Squibb & Sons, L.L.C. ($174.64) |
| 2018 | $566.32 | 36 | Janssen Pharmaceuticals, Inc ($159.41) |
| 2017 | $635.66 | 43 | E.R. Squibb & Sons, L.L.C. ($154.83) |
All Payment Transactions
163 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/17/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $146.24 | General |
| Category: Neuroscience | ||||||
| 09/13/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $20.34 | General |
| Category: Cardiovascular | ||||||
| 08/02/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $38.30 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 05/25/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $19.55 | General |
| Category: CARDIOVASCULAR | ||||||
| 05/10/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $29.98 | General |
| 04/26/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $30.23 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 03/15/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $15.75 | General |
| Category: Cardiovascular | ||||||
| 02/23/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $20.06 | General |
| Category: DIABETES | ||||||
| 12/08/2023 | ABBVIE INC. | TEFLARO (Drug) | Food and Beverage | In-kind items and services | $27.03 | General |
| Category: ANTI-INFECTIVE | ||||||
| 12/01/2023 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $42.02 | General |
| Category: Neuroscience | ||||||
| 10/13/2023 | ABBVIE INC. | TEFLARO (Drug) | Food and Beverage | In-kind items and services | $19.56 | General |
| Category: ANTI-INFECTIVE | ||||||
| 09/29/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $20.48 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 08/25/2023 | ABBVIE INC. | TEFLARO (Drug) | Food and Beverage | In-kind items and services | $20.08 | General |
| Category: ANTI-INFECTIVE | ||||||
| 03/31/2023 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug) | Food and Beverage | In-kind items and services | $22.65 | General |
| Category: Cardiology | ||||||
| 01/20/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $20.21 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 10/28/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $12.43 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 09/16/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug), STIOLTO RESPIMAT, SPIRIVA RESPIMAT | Food and Beverage | In-kind items and services | $24.36 | General |
| Category: DIABETES | ||||||
| 07/22/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $30.10 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 06/24/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $19.21 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 04/13/2022 | AstraZeneca Pharmaceuticals LP | BRILINTA (Drug) | Food and Beverage | In-kind items and services | $14.40 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/04/2022 | AstraZeneca Pharmaceuticals LP | BRILINTA (Drug) | Food and Beverage | In-kind items and services | $19.04 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 02/18/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug), SPIRIVA RESPIMAT | Food and Beverage | In-kind items and services | $24.25 | General |
| Category: DIABETES | ||||||
| 02/04/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug), SPIRIVA RESPIMAT | Food and Beverage | In-kind items and services | $15.79 | General |
| Category: DIABETES | ||||||
| 01/20/2022 | AstraZeneca Pharmaceuticals LP | BRILINTA (Drug) | Food and Beverage | In-kind items and services | $12.04 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 12/09/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $31.30 | General |
| Category: Cardiovascular & Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 580 | 1,012 | $351,413 | $76,877 |
| 2022 | 6 | 594 | 1,049 | $356,476 | $79,845 |
| 2021 | 6 | 713 | 1,257 | $429,127 | $100,875 |
| 2020 | 7 | 752 | 1,300 | $432,877 | $104,819 |
All Medicare Procedures & Services
24 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 207 | 605 | $160,325 | $36,824 | 23.0% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 190 | 199 | $77,809 | $17,548 | 22.6% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 86 | 87 | $64,032 | $11,161 | 17.4% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 69 | 93 | $35,247 | $8,522 | 24.2% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 28 | 28 | $14,000 | $2,822 | 20.2% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 188 | 339 | $122,703 | $27,610 | 22.5% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 141 | 435 | $109,763 | $25,134 | 22.9% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 161 | 169 | $62,963 | $14,076 | 22.4% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 65 | 67 | $46,967 | $9,959 | 21.2% |
| 99217 | Hospital observation care on day of discharge | Facility | 2022 | 28 | 28 | $7,084 | $1,546 | 21.8% |
| 99220 | Initial hospital observation care per day, typically 70 minutes | Facility | 2022 | 11 | 11 | $6,996 | $1,520 | 21.7% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 235 | 492 | $172,032 | $40,411 | 23.5% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 146 | 417 | $101,836 | $24,117 | 23.7% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2021 | 195 | 206 | $74,058 | $17,449 | 23.6% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 86 | 90 | $61,682 | $14,338 | 23.2% |
| 99220 | Hospital observation care, typically 70 minutes | Facility | 2021 | 18 | 18 | $11,214 | $2,609 | 23.3% |
| 99217 | Hospital observation care on day of discharge | Facility | 2021 | 33 | 34 | $8,305 | $1,952 | 23.5% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 189 | 601 | $144,664 | $35,087 | 24.3% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 188 | 305 | $105,918 | $25,825 | 24.4% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 105 | 111 | $75,738 | $18,243 | 24.1% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2020 | 188 | 197 | $70,468 | $17,147 | 24.3% |
| 99220 | Hospital observation care, typically 70 minutes | Facility | 2020 | 29 | 30 | $18,690 | $4,418 | 23.6% |
| 99217 | Hospital observation care on day of discharge | Facility | 2020 | 36 | 39 | $9,516 | $2,243 | 23.6% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2020 | 17 | 17 | $7,883 | $1,856 | 23.5% |
About Dr. Khushboo Patel, M.D
Dr. Khushboo Patel, M.D is a Internal Medicine healthcare provider based in Altoona, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/30/2010. The National Provider Identifier (NPI) number assigned to this provider is 1548564891.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Khushboo Patel, M.D has received a total of $2,869 in payments from pharmaceutical and medical device companies, with $320.45 received in 2024. These payments were reported across 163 transactions from 14 companies. The most common payment nature is "Food and Beverage" ($2,865).
As a Medicare-enrolled provider, Patel has provided services to 2,639 Medicare beneficiaries, totaling 4,618 services with total Medicare billing of $362,416. Data is available for 4 years (2020–2023), covering 24 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Altoona, PA
- Active Since 12/30/2010
- Last Updated 10/19/2011
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1548564891
Products in Payments
- XARELTO (Drug) $854.00
- ELIQUIS (Drug) $628.20
- ENTRESTO (Drug) $370.56
- INVEGA SUSTENNA (Drug) $188.26
- TEFLARO (Drug) $175.50
- ZERBAXA (Drug) $104.47
- BRILINTA (Drug) $99.03
- LifeVest (Device) $91.70
- JARDIANCE (Drug) $84.46
- AVYCAZ (Drug) $59.74
- JANUVIA (Drug) $37.71
- PRADAXA (Drug) $29.43
- Soliris (Drug) $23.83
- Cimzia (Drug) $22.81
- OPSUMIT (Drug) $22.65
- VYNDAQEL (Drug) $19.55
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Altoona
Dr. Mitul Patel, Md, MD
Internal Medicine — Payments: $110,465
Dr. Medhat Zaher, Md, MD
Internal Medicine — Payments: $7,312
Zane Gates, M.d, M.D
Internal Medicine — Payments: $5,749
James Gerardo, M.d., Ph.d, M.D., PH.D
Internal Medicine — Payments: $3,375
Dr. Jignesh Patel, Md, MD
Internal Medicine — Payments: $2,853
Anju Gupta, M.d, M.D
Internal Medicine — Payments: $1,805